に関する追加情報 7 Keto Abiraterone Acetate
親薬物
AbirateroneIUPAC名
(3S, 8R, 9S, 10R, 13S, 14S)-10, 13-Dimethyl-7-oxo-17-(pyridin-3-yl)-2, 3, 4, 7, 8, 9, 10, 11, 12, 13, 14, 15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl Acetate薬局方同義語
N/AOther Synonyms
N/ASMILES
CC(O[C@H](CC1=C2)CC[C@]1(C)[C@@]3([H])CC[C@]4(C)C(C5=CC=CN=C5)=CC[C@@]4([H])[C@]3([H])C2=O)=OInchl
InChI=1S/C26H31NO3/c1-16(28)30-19-8-10-25(2)18(13-19)14-23(29)24-21-7-6-20(17-5-4-12-27-15-17)26(21,3)11-9-22(24)25/h4-6,12,14-15,19,21-22,24H,7-11,13H2,1-3H3/t19-,21-,22-,24-,25-,26+/m0/s1説明
The compound 7 Keto Abiraterone Acetate is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines, including those from USP, EMA, JP, and BP. It is ideal for critical applications such as analytical method development, method validation (AMV), and quality control (QC), especially in the production of Abiraterone. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), this product delivers the precision required for reliable results. Additionally, it includes a detailed Structure Elucidation Report (SER), ensuring accuracy and dependability for advanced analytical purposes. 7 Keto Abiraterone Acetate or (3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-7-oxo-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl Acetate, is an antiandrogen class and it is a used in the treatment a certain type of prostate cancer.
References
Thakur, Abhimanyu, et al. “Abiraterone Acetate in the Treatment of Prostate Cancer.†Biomedicine & Pharmacotherapy, vol. 101, May 2018, pp. 211–218, 10.1016/j.biopha.2018.02.067.見積もり依頼
「*」は必須フィールドを示します









